About
Accipiter Biosciences uses computational protein design to develop de novo multifunctional protein biologics that activate multiple cell-surface receptors for treating complex diseases such as autoimmune disorders and cancer.
Explore Accipiter Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.